Canary Wharf Group and Kadans Science Partner have been given the go-ahead for the development of a health and life sciences building at the North Quay site in Canary Wharf, E14.
The 23-storey tower is set to create a vertical campus, which the partners said would be Europe’s largest and most technologically advanced life sciences facility.
The 823,000 sq ft building is expected to provide enhanced fresh air, power, data and ceiling heights, in comparison to a traditional commercial lab building or converted office.
Enabling works on the 8.2-acre site are already under way and will complete in 2027.
Michel Leemhuis, chief executive at Kadans Science Partner, said: “In addition to its scale, location and technology, this building sets a new benchmark in its field for sustainability, capitalising on our previous experience and lessons learned, while engaging industry working groups to ensuring we are delivering a facility tailor-made to industry requirements.”
Shobi Khan, chief executive at Canary Wharf Group, added: “While the North Quay development is an integral focal point, we have been working in tandem to nurture and grow our current life sciences community and we have built real momentum this year through leasing success and working with our partner Kadans to develop bespoke and innovative new facilities.
“The next chapter in the evolution of Canary Wharf is well under way, with the next generation of health and life science companies set to become a significant presence in our sustainable, mixed-use environment.”
To send feedback, e-mail evelina.grecenko@eg.co.uk or tweet @Gre_Eve or @EGPropertyNews
